🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareRetatrutide anticipation thread — what are your questions for Phase 3? Page 6

Retatrutide anticipation thread — what are your questions for Phase 3?

rick_sfbay Mon, Mar 23, 2026 at 11:14 PM 32 replies 903 viewsPage 6 of 7
nick_newbie
New Member
18
56
Jun 2026
Virginia
Online
Apr 25, 2026 at 11:03 AM#26
rachel_ABQ said:
The useful move here is to separate what is established from what is widely repeated.

This matches mine closely enough to be worth saying so out loud. Posting only so the count is not one.

Last edited: Apr 25, 2026 at 2:03 PM
6 4robert_kc, dan_philly, MeganSA_TX and 3 others
Reply Quote Save Share Report
mia_MS2
New Member
8
23
Jun 2026
Ann Arbor, MI
Apr 29, 2026 at 6:02 PM#27
rachel_ABQ said:
The useful move here is to separate what is established from what is widely repeated.

Coming at rachel_ABQ’s question from a different direction. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

Last edited: Apr 29, 2026 at 9:02 PM
7 5FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 4 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
May 4, 2026 at 12:59 AM#28

Adding the numbers, since they settle part of this. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

Last edited: May 4, 2026 at 6:59 AM
8 6RetaRick_CA, JenPlateau, SallyK_inj and 5 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 8, 2026 at 7:53 AM#29

One thing that is still open after rachel_ABQ’s answer:

What would you measure differently if you were starting again?

9 7BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 6 others
Reply Quote Save Share Report
rick_sfbay
Member
289
1,234
Jan 2025
San Francisco, CA
May 12, 2026 at 2:44 PM#30

OP back with an update, since a thread like this is useless without one.

Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have. That was reassuring rather than otherwise.

31 4Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 28 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register